Latest Breaking News On - Dana flanders - Page 5 : comparemela.com

Operator Ladies and gentlemen, thank you for standing by, and welcome to the Ligand Pharmaceuticals Q4 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Patrick O Brien. Thank you. Please go ahead. Patrick O Brien Investor Relations Thank you, Brandy. And welcome to Ligand s fourth quarter of 2020 financial results and business update conference call. All of our speakers for today s call are in separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO. We will use non-GAAP financial measures and some of our statements will be forward-looking. Additional information concerning risk factors and other matters concerning Ligand can be found in our Ligand s earning press release and our periodic filings with the SEC. Ligand undertakes no obligation to revise or update any statements to reflect events or circumstances after the date of this conference call.

United statesMatt hewittPatrick obrienMatt foehrMatthew foehrMatt korenbergBalaji prasad barclaysJohn higginsJoe pantginisBalaji prasadScott henryDana flandersMatt hewitt craig hallum capital group analystLigand pharmaceuticalsLigand pharmaceuticals incJazz pharmaceuticals